INS and early-onset autosomal dominant Alzheimer disease: Insulin, insulin-like growth factor-1, and neurotrophin intranasal delivery has been suggested as a way to compensate for the neural damage caused by diabetes, stroke, diabetes, Alzheimer's disease, and HIV.